Satellite Banner
Technology Networks Header
Saturday, October 25, 2014
 
Register | Sign in
Home Page>Products
  Product News
Fluidigm’s New Juno™ System Shatters Barriers for SNP Genotyping
Friday, September 19, 2014
New system provides simple workflow, requires minimal amount of sample input and hands-on time.

Tecan Offers NGS Sample Preparation at the Touch of a Button
Friday, September 19, 2014
Tecan’s Freedom EVO NGS workstation to offer robust and reliable automation.

Microvisk: ‘World First’ Medical Device Accredited for European Sales
Friday, September 19, 2014
Solid state technology unique in medical diagnostics.

Pexip® Introduces Infinity Connect
Friday, September 19, 2014
Visual meetings on any device simplified with installable client software supporting major desktop operating systems and all major browsers.

Bruker Launches the First Guaranteed AFM TERS Solution
Friday, September 19, 2014
New Innova-IRIS uniquely addresses challenging TERS research.

Malvern Explores Rheology for Protein Formulation at 2nd Protein-Protein Interaction Conference
Thursday, September 18, 2014
Malvern Instruments will contribute a scientific poster at the 2014 Protein-Protein Interaction Conference, October 23-24, Boston, MA, USA.

Phenomenex Expands its Aeris® PEPTIDE Core-Shell Column Line
Thursday, September 18, 2014
The line now includes a 5 µm particle size for small-scale purifications.

Enhance Sample Preconcentration and Reduce Workflow
Thursday, September 18, 2014
New method developed by Thermo Fisher Scientific using solid-phase extraction well plates.

Respected Synthetic Biology Group Chooses G:BOXChemi XT4
Wednesday, September 17, 2014
To speed up analysis of DNA and proteins from bacteria engineered to process heavy metals accumulated in plants grown on contaminated soil.

<< 7 8 9 10 11 12 13 >>
Showing Results 91 - 100 of 10591
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv